Temozolomide-induced vitiligo-like reaction: An extremely rare phenomenon

Temozolomide (TMZ) is an alkylating chemotherapeutic drug, often used in high-grade glioma and metastatic melanoma. Common side effects of this include myelosuppression and gastrointestinal side effects. Vitiligo-like reaction is extremely rare after TMZ. Here, we report a case of a 55-year-old pati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and therapeutics 2023-12, Vol.19 (Suppl 2), p.S896-S897
Main Authors: Madan, Renu, Raja, M Karthik, Mahajan, Rahul, Goyal, Shikha
Format: Article
Language:English
Subjects:
Adverse and side effects
Causes of
Complications and side effects
Diagnosis
Dosage and administration
Drug therapy
Drugs
Glioblastoma multiforme
Glioma
Pigmentation disorders
Temozolomide
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Temozolomide (TMZ) is an alkylating chemotherapeutic drug, often used in high-grade glioma and metastatic melanoma. Common side effects of this include myelosuppression and gastrointestinal side effects. Vitiligo-like reaction is extremely rare after TMZ. Here, we report a case of a 55-year-old patient of glioblastoma who developed vitiligo-like reaction after starting adjuvant TMZ.
ISSN:0973-1482
1998-4138
DOI:10.4103/jcrt.jcrt_2037_21